HRT -Hormone Replacement Therapy in Northvale, NJ.
201-292-0706
Enjoying Life Without Compromise: HRT for Women in Northvale, NJ
If there's one universal truth, it's that all of our bodies begin changing at some point. That's especially true for women who are over the age of 50. One day it seems like we're rolling out of bed with a pep in our step. The next, our emotions are out of control, our weight won't go down, and we constantly have hot flashes. If that sounds like you, don't worry – millions of other women worldwide are going through the same difficulties.
The fact of the matter is these symptoms are part of a natural process women go through. This change, called menopause, marks the end of a woman's ability to reproduce and menstruate. The average age for this to occur is 51, though it officially begins a year after a woman's final period. During this transition to menopause, estrogen and other hormones in a woman's body start to deplete When those hormones deplete, frequent and sometimes severe symptoms can manifest:
The symptoms of hormone deficiency can be scary for both women and their partners. That makes dealing with a hormone deficiency tricky because many symptoms are tied to nutrition, stress, lack of exercise, and toxins in your body.
However, if you're getting older and dealing with some of the symptoms listed above, have hope. A solution to your hormone problems may be closer than you think. Hormone replacement therapy for women may help correct imbalances caused by menopause. These effective, safe treatments help many women throughout the menopause process and may even help them reclaim their youth.
Our HRT Services
- Enjoying Life Without Compromise: HRT for Women in Northvale, NJ
- The Juventee Difference
- Juventee's Custom HRT Treatments for Women
- Benefits of HRT for Women in Northvale, NJ
- Common Issues Women Experience During Menopause
- A New Youthful You Awaits at Juventee TRT in Northvale, NJ
Services Area
Is HRT for Women the Right Answer?
To live a healthy life, hormone stability is very important for women. That's where the beauty of HRT treatments for women begins to shine because it balances hormones that would otherwise be altered due to menopause.
HRT treatments for women represent a revolutionary step toward living life without the pitfalls of old age. However, at Juventee, we understand that no two women, and by proxy, patients, are the same. That's why our team of doctors and specialists provide personalized treatment options for women, combining holistic treatment, nutrition, fitness plans, and more to supplement our HRT treatments.
Is HRT the answer if you feel exhausted, overweight, and moody? That's the million-dollar question that we're asked almost every day. And to be honest, it's hard to say without a comprehensive exam by an HRT expert at Juventee. What we can say is that when a woman's hormones are better balanced during menopause, she has a much better chance of enjoying life without the crippling symptoms that other women feel.
At Juventee, helping women reclaim their vitality and love of life is our top priority. While some HRT clinics see patients as nothing more than a means to make money, our team is cut from a different cloth.
The Juventee Difference
The key to balancing your hormones and improving your well-being is a process that we have refined over time. The Juventee HRT process consists of a comprehensive review of your health and hormonal status. Our team then customizes your plan and prescribes treatments, procedures, and supplements under the guidance of our local HRT experts.
At Juventee, we want to revitalize your health by promoting balance, energy, intimacy, and beauty. We start by assessing your baseline biomarkers and implementing a personalized plan to help you feel like your younger self. Our in-depth process covers many factors, almost like a web. Each component of that web works in conjunction with others to make up how you feel. If one area is out of sync, women can experience unwanted fluctuations in their weight, energy, emotions, libido, and more. Juventee is committed to evaluating our patient's overall health so that we may bring vitality and happiness to as many aspects of their lives as possible.
We've mentioned all the greatness that can come with an HRT regimen from Juventee, but what exactly are the benefits of HRT for women? Let's take a look.
We Work With
Juventee's Custom HRT Treatments for Women
Unlike some HRT clinics, Juventee's HRT programs are carefully crafted and personalized for each patient. There are no cookie-cutter solutions at our office. Instead, we assess each individual's needs and customize treatments to help their bodies as they age. We replace hormones that are deficient and restore them to their physiological state using HRT pellets.
These hormone pellets are prescription hormones inserted under the skin through a simple in-office procedure. Each pellet is about as large as a big grain of rice. Once inserted, our HRT pellets get to work quickly. With this treatment, patients don't have to worry about applying greasy creams or swallowing pills. Instead, our pellets are metabolized by the body. That way, patients don't stress over taking too much or too little.
Remember, at Juventee, our goal isn't just to balance your hormones – it's to completely optimize your health and well-being. You won't ever have to worry about our doctors writing you a prescription and sending you on your way without any additional communication. Instead, we aim to be part of our patient's journey back to health and work with all of our HRT patients to do so.
Benefits of HRT for Women in Northvale, NJ
Hormone imbalance causes a litany of issues. But with hormone replacement therapy, females can better process calcium, keep their cholesterol levels safe, and maintain a healthy vagina. By replenishing the body's estrogen levels, HRT may relieve symptoms of menopause and even optimize bone health.
But that's just the start. At Juventee, our patients report many benefits of taking HRT for women:
- Less Chance of Depression
- Better Sleep
- Healthier Libido
- Not As Many Hot Flashes
- Optimal Vaginal Health
- Better Levels of Cholesterol
- Improved Memory & Concentration
- Improved Strength & Muscle Mass
- Less Risk of Breast Cancer
- Less Risk of Alzheimer's Disease
If you're ready to feel better and enjoy the vitality of your youth, Juventee is here to help you every step of the way. It all starts with an in-person evaluation, where our team will determine if HRT is right for you.
Common Issues Women Experience During Menopause
For many women, menopause is a difficult time filled with ups, downs, and hormonal hurdles to overcome. While menopausal issues are well-known by some, other women only know that menopause can affect their hormones. The reality is that going through menopause can mean more than moodiness and hot flashes.
At Juventee, we're big believers that a little knowledge can go a long way. With that in mind, if you're going through menopause or are approaching "that" age, consider these common issues. First, let's examine some alternative causes of menopause beyond age:
What Causes Menopause?
The most common reason for menopause is diminished, unbalanced hormones. However, menopause can also result from:
- Oophorectomy: This surgery removes a woman's ovaries and causes immediate menopause. In this situation, symptoms of menopause can be serious, as hormonal changes happen abruptly.
- Chemotherapy: Cancer treatments can cause menopause quickly, with symptoms appearing shortly after treatment.
- Ovarian Insufficiency: Referred to as premature ovarian failure, this condition happens when a woman's ovaries lose function prior to 40. Only 1% of females experience premature menopause, but HRT can help protect the heart, brain, and bones.
Now that we've examined some of the ways that menopause manifests, let's look at some common problems that females regularly endure:
Depression
If you're going through menopause and feel like life is a tiresome burden, you're not alone. Studies show that 15% of women go through depression to some degree during menopause. What many women don't learn is that depression may start much earlier, during perimenopause or even earlier.
Depression can be hard to diagnose, even without perimenopause and menopause as a factor. With that said, keep the following signs in mind. If you notice any, it might be time to speak with a physician:
- Feelings of Being Overwhelmed
- Lack of Interest
- Mood Swings
- Chronic Exhaustion
- Too Much Sleep
- Too Little Sleep
- Inappropriate Guilt
If you notice any of the signs above, it's important that you understand that you're not weak or broken. You're going through a very normal emotional experience, which may be caused by hormone deficiency. However, with proper treatment from your doctor, depression doesn't have to rule your life.
Mood Swings
You don't have to have hormonal imbalances to have mood swings. Indeed, everyone gets moody from time to time. For women going through menopause, however, mood swings can be extreme and happen often. Hormone imbalances and mood swings go together, resulting in unusual emotional changes and even issues like insomnia.
Estrogen production, a hormone that fluctuates during menopause, affects serotonin production, which regulates mood. When both hormones are deficient, mood swings can become quite prevalent.
Fortunately, HRT treatments in Northvale, NJ, work wonders for women because they work to regulate hormones like estrogen. With HRT from Juventee, women don't have to settle for the negative consequences that drastic mood swings can cause.
Hot Flashes
Hot flashes: whether you're a man or a woman, you've probably heard of them. Hot flashes are very common issues associated with menopause and manifest as intense, sudden feelings of heat across the upper body. Some last a few seconds while others last many minutes, making them uncomfortable and inconvenient at all times. A few common symptoms of hot flashes include:
- Overwhelming and Intense Sensations of Heat
- Nausea
- Anxiety
- Increased Heart Rate
- Dizziness
- Headaches
Usually, a lack of estrogen causes hot flashes in menopausal women. Low levels of estrogen negatively affect a woman's hypothalamus, or the part of the brain that regulates appetite and body temperature. Low estrogen levels cause the hypothalamus to assume incorrectly that the body is too hot. When it does, it dilates a woman's blood vessels to boost blood flow.
Fortunately, most women don't have to settle for the intense, unwanted feelings they endure with hot flashes. HRT pellet treatment from Juventee helps to stabilize hormones which may lessen the effects that hot flashes cause.
Weight Gain
Staying healthy and fit is a challenge for anybody living in modern America. For women with hormonal imbalances, however, it's even harder. Weight gain is a concerning issue during menopause, but it can be manageable with a physician-led diet, exercise, and HRT treatments from Juventee.
HRT patients at Juventee benefit from health plans that keep hormones in check, making weight loss a real possibility. But which hormones need to be regulated to help avoid weight gain?
- Progesterone: Depleted levels of progesterone may cause bloating and water retention, while loss of testosterone affects the ability to burn calories.
- Estrogen: As you know by now, estrogen levels are often imbalanced during menopause. As such, the body searches for other sources of the hormone. Because estrogen is stored in fat cells, your body thinks it needs to increase fat production to obtain more. The hormone also plays a big part in insulin resistance, which can make weight loss during menopause even harder.
- Chronic Stress: When we're stressed, our body's response is to believe that food is scarce. When this happens, our bodies go into "survival mode." During this process, cortisol production is altered. When cortisol timing changes, your body works harder to produce fat. With chronic stress, this process repeatedly happens, leading to extreme weight gain during menopause.
Low Libido
Millions of adults around the U.S. suffer from low sex drive, but that doesn't make it any more embarrassing to talk about. For many women going through pre-menopause and menopause, it's an unfortunate side effect of unbalanced hormones. Thankfully, HRT may help women maintain a healthy libido, even after 50. But what causes lowered sexual desire in women as they age?
The hormones responsible for low libido in females are estrogen, progesterone, and testosterone.
Progesterone production decreases during perimenopause, resulting in lowered libido in some women. Lower progesterone production can also cause weight gain, exhaustion, and other symptoms common during menopause. Reduced estrogen levels during menopause may lead to vaginal dryness and even loss of muscle tension.
Testosterone is referred to as a male hormone, but it contributes to important health functionality in women as well. Female testosterone heightens sexual responses and intensifies orgasms. When the ovaries can't produce sufficient levels of testosterone, low sex drive can happen.
Bone Density Loss
The inside of a woman's bones is broken down and rebuilt by bone cells in an ongoing process called remodeling. This process is crucial for maintaining bone strength and health.
However, due to the loss of estrogen during menopause, this important process becomes unbalanced. Less bone is formed, and more bone is broken down. This advanced state of bone loss can be worrying for women, especially if they had an early menopause. With time, women may develop osteoporosis and a greater chance of breaking bones as they age.
Fortunately, HRT for women can actually mimic estrogen and progesterone, which may help prevent bone loss and lower chances of osteoporosis in women. That's huge news for women around the U.S., many of whom are battling early bone loss due to a lack calcium, vitamin D, and other nutrients crucial to bone health.
A New Youthful You Awaits at Juventee
If you are considering HRT treatments for women in Northvale, NJ, you need a team of hormone replacement experts by your side. At Juventee, our knowledgeable HRT doctors are ready to help. Our team will answer your initial questions, conduct necessary testing, and craft a customized program designed to alleviate the challenges you're facing as a woman going through menopause.
With a healthy diet, exercise, positive life choices, and hormone replacement therapy, unveiling the new "you" is easier than you might think. Contact our office today to get started on your journey to optimal health and well-being.
Latest News in Northvale, NJ
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - February 7, 2023
BioSpacehttps://www.biospace.com/article/elite-pharmaceuticals-reports-positive-results-from-a-pivotal-bioequivalence-study-february-7-2023/
NORTHVALE, NJ / ACCESSWIRE / February 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported positive results from pivotal fasted bioequivalence studies for an undisclosed generic drug product in a class of medications called antimetabolites . IQVIA reported annual sales for the...
NORTHVALE, NJ / ACCESSWIRE / February 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported positive results from pivotal fasted bioequivalence studies for an undisclosed generic drug product in a class of medications called antimetabolites . IQVIA reported annual sales for the twelve months ending December 2022 of $42 million for the generic market for this product.
The studies were open label, single-dose crossover comparative bioavailability studies in volunteers of male and female patients who were already on established drug regimens under fasting conditions. The results indicate that the generic product is bioequivalent to the branded product. Elite is compiling the data for this product to file an Abbreviated New Drug Application with the US Food and Drug Administration.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release. Readers are cautioned that such forward-looking statements involve, without limitation, risks, uncertainties, and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These forward-looking statements may include statements regarding the expected timing of approval, if at all, of products by the FDA, and the actions the FDA may require of Elite in order to obtain such approvals. These forward-looking statements are not guarantees of future action or performance. These risks and other factors are discussed, without limitation, in Elite's filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q, and 8-K. Elite is under no obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: Elite Pharmaceuticals, Inc. Dianne Will, Investor Relations 518-398-6222 [email protected]
SOURCE: Elite Pharmaceuticals, Inc.
View source version on accesswire.com: https://www.accesswire.com/738300/Elite-Pharmaceuticals-Reports-Positive-Results-from-a-Pivotal-Bioequivalence-Study
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information
ACCESSWIRE News Roomhttps://www.accesswire.com/739342/Elite-Pharmaceuticals-Inc-Reports-Financial-Results-for-the-Third-Quarter-of-Fiscal-Year-2023-ended-December-31-2022-and-Provides-Conference-Call-Information
Conference Call Scheduled for Wednesday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third quarter of fiscal year 2023 ended December 31, 2022 ("Third Quarter").Consolidated revenues for the three-month period ended December 31, 2022, were $9.3 million, an increase...
Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST
NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third quarter of fiscal year 2023 ended December 31, 2022 ("Third Quarter").
Consolidated revenues for the three-month period ended December 31, 2022, were $9.3 million, an increase of $0.30 million or 3% as compared to the comparable period of the prior fiscal year. The increase was primarily attributed to revenues from generic immediate-release Adderall® and generic extended-release Adderall®. Operating profits were $2.0 million, an increase of $0.12 million from the prior year's comparable period, and net income was $2.96 million.
Consolidated revenues for the nine-month period ended December 31, 2022, were $25.5 million, an increase of $0.90 million or 4% as compared to the comparable period of the prior fiscal year. The increase was primarily attributed to revenues from generic immediate-release Adderall® and generic extended-release Adderall®. Operating profits were $4.1 million, a decrease of $0.10 million from the comparable period of the prior year, and net income was $4.79 million.
Conference Call Information
Elite's management will host a conference call to discuss the Third Quarter financial results and provide an update on recent business developments. Stockholder questions should be submitted to the company in advance of the call.
The financial statements can be viewed for Elite's Third Quarter of Fiscal Year 2023 on Form 10-Q here.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release. Readers are cautioned that such forward-looking statements involve, without limitation, risks, uncertainties and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These forward-looking statements may include statements regarding the expected timing of approval, if at all, of products by the FDA, and the actions the FDA may require of Elite in order to obtain such approvals. These forward-looking statements are not guarantees of future action or performance. These risks and other factors are discussed, without limitation, in Elite's filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q, and 8-K. Elite is under no obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:For Elite Pharmaceuticals, Inc.Dianne Will, Investor Relations, 518-398-6222[email protected]www.elitepharma.com
SOURCE: Elite Pharmaceuticals, Inc.
Topic:
Earnings
Bakery chain announces another N.J. opening amid nationwide expansion
njhttps://www.nj.com/business/2022/08/bakery-chain-announces-another-nj-opening-amid-nationwide-expansion.html
Bakery cafe chain Paris Baguette is continuing its nationwide expansion with another planned opening in the Garden State.Paris Baguette recently revealed plans to open in Plainsboro to NJ Advance Media.An exact location and opening date have yet to be determined for the cafe, although it is expected to open early 2023.The Plainsboro location will join spots in Cherry Hill, Livingston, Montgomery, Montvale, Northvale, Paramus, Red Bank and West N...
Bakery cafe chain Paris Baguette is continuing its nationwide expansion with another planned opening in the Garden State.
Paris Baguette recently revealed plans to open in Plainsboro to NJ Advance Media.
An exact location and opening date have yet to be determined for the cafe, although it is expected to open early 2023.
The Plainsboro location will join spots in Cherry Hill, Livingston, Montgomery, Montvale, Northvale, Paramus, Red Bank and West New York that are also slated to open soon in the Garden State.
The company is planning to open 1,000 stores in the United States by 2030.
Paris Baguette offers a variety of daily-baked goods, such as whole cakes, cake slices, breads, donuts, croissants and roll cake. Its menu also features salads, sandwiches, coffee and tea.
The Korean-based cafe chain debuted in the United States in 2005.
It operates 105 locations nationwide, with 31 spots coming soon according to the company’s website.
There are seven Paris Baguette locations in New Jersey.
RELATED STORIES ABOUT RETAIL AND SHOPPING:
Michaels to open another N.J. store later in 2022
N.J. appliance store closing after 67 years in business
Italy rejects Domino’s pizza, forcing chain to close all restaurants in the country
Our journalism needs your support. Please subscribe today to NJ.com.
Christopher Burch can be reached at [email protected]. Follow him on Twitter: @ChrisBurch856. Find NJ.com on Facebook. Have a tip? Tell us. nj.com/tip
The Dominguez Brothers and Alexander Dillon Offer Up A Unique Dining Experience at Olar Noso
Yahoo! Newshttps://finance.yahoo.com/news/dominguez-brothers-alexander-dillon-offer-154000483.html
If a restaurant can be both tucked and perched, that's the setting Olar Noso occupies on a freshly manicured corner in Northvale, NJ. Olar Noso is often called a neighborhood restaurant, but all neighborhoods should be so lucky.NEW YORK, NY / ACCESSWIRE / April 8, 2022 /The past few years have been nothing short of trying times for the restaurant industry. Even so, it is exciting to see young and talented entrepreneurs stepping up to provide unique dining experiences for local restaurant-goers ...
If a restaurant can be both tucked and perched, that's the setting Olar Noso occupies on a freshly manicured corner in Northvale, NJ. Olar Noso is often called a neighborhood restaurant, but all neighborhoods should be so lucky.
NEW YORK, NY / ACCESSWIRE / April 8, 2022 /The past few years have been nothing short of trying times for the restaurant industry. Even so, it is exciting to see young and talented entrepreneurs stepping up to provide unique dining experiences for local restaurant-goers that have long desired something new. That is exactly what Matt and Marcus Dominguez are doing alongside Alexander Dillon at Olar Noso. Olar Noso is the areas newest establishment generating a significant buzz among locals and loyal patrons eagerly awaiting the rebirth of a long-time favorite destination. Olar provides a lively atmosphere not often available outside the city, it's quickly emerging as the sophisticated but comfortable restaurant our area needed.
The name Olar Noso comes from a northern Spanish dialect meaning "our home", it's a true family-owned restaurant founded by the Dominguez brothers and backed by childhood friend Alexander Dillon. Matt Dominguez has more than ten years of restaurant experience working alongside his father, Miguel, at the wildly famous Olar location in Piermont. Since the pandemic, northern New Jersey has undergone somewhat of a suburban renaissance, the influx of young New Yorkers to the Bergen County area provides for the perfect opportunity to bring a restaurant like Olar Noso to life.
Olar Noso Features a Casual Upscale Menu
At Olar Noso, it's all about the food! The official description is "Mediterranean cuisine" but our best characterization is a fusion of Spanish and Italian flare. Patrons can enjoy delicious, gourmet pizzas that can be paired beautifully with traditional Spanish dishes, such as paella. The menu is expanded nightly with additional offerings of chef specials including some delicious twists on traditional tapas recipes. Olar also offers a fun bar scene on weekends, with specialty cocktails and a wine list procured by the owners and expert sommeliers. The team, now known as 3D Hospitality, has aspirations of being named one of New Jersey's few Michelin-star restaurants.
View source version on accesswire.com:
Coldwell Banker Realty Celebrates Grand Opening of New Phase at Paris Square Active Adult Community
REWhttps://rew-online.com/coldwell-banker-realty-celebrates-grand-opening-of-new-phase-at-paris-square-active-adult-community/
Anne Van Dyke from Coldwell Banker Realty’s Closter/Alpine Office and Coldwell Banker Realty New Homes, a leading sales and marketing organization in the homebuilding industry, announce the grand opening of The Monroe and Madison Building at ...
Anne Van Dyke from Coldwell Banker Realty’s Closter/Alpine Office and Coldwell Banker Realty New Homes, a leading sales and marketing organization in the homebuilding industry, announce the grand opening of The Monroe and Madison Building at Paris Square, a ten-building, 111-residence, 50+ active adult condominium community located at 199 Paris Avenue in Northvale, N.J. Anne Van Dyke and Coldwell Banker Realty New Homes are serving as the sales and marketing team for the community.
The milestone is the latest success story for the Coldwell Banker Realty New Homes team in driving results on behalf of developers, builders and Realtors across New Jersey. Prior to Coldwell Banker Realty New Homes’ involvement, Paris Square had undergone a lengthy 15-year construction process that had only resulted in the completion of half of its planned units. Years of no activity, a lengthy construction process, and the uninspiring marketing of the completed units over its history had led to equally underwhelming sales velocity and a reputation in the local market as a community geared towards the 75-year-old plus age group, rather than one focused on empty nesters from 50-years-old and up.
However, a new developer, Alvin Sarter of Treuhold Capital Group, a New York-based real estate investment company, acquired the property intending to resuscitate it as a destination for active adults in northern New Jersey. Immediately, Alvin knew that it would also be critical to “reintroduce” the community to the local market by creating an A-team of local professionals known for their financial acumen of the market, reputation for quality construction and keen marketing skills. Recognizing their track record of success with similar assignments, he selected the Coldwell Banker Realty New Homes team and Anne Van Dyke from Coldwell Banker’s Closter/Alpine Office as well as local builder Ray Reduce Development, residential designer Deb Franklin, and local lenders Procida Capital and ConnectOne Bank to bring the project to the market.
“Coldwell Banker Realty New Homes understood the value proposition presented by Paris Square relative to the market area competition and immediately set out to implement a sales and marketing strategy to effectively deliver this message to the local community,” said Sarter. “They know exactly what buyers are interested in when buying new construction – particularly in an age-restricted community and focused their efforts on leveraging the quality of what we were building with the amenities package offered at Paris Square.”
Aimed at “junior seniors” (55-74 years old), Paris Square now features a range of one, two and three-bedroom residences ranging from 820 to 1,537 square feet. Every home also offers 9’ ceilings, wide plank wood flooring, shaker-style cabinetry, quartz countertops, GE stainless appliances and Kohler faucets among other living comforts.
Paris Square also boasts a community clubhouse, heated pool, walking path and park, fitness room, stadium-seat theatre, game room, putting green and on-site garage parking. The community is nearby many local attractions such as Rockleigh Golf Course, Rockleigh Equestrian Centre and numerous upscale dining and shopping options.
Through the combined efforts of the team, Paris Square’s Jefferson Building was sold out prior to its completion. In addition, pre-construction sales for the remaining residences have been robust with 40% already sold. Construction for the full community is scheduled for completion in 1Q of 2023.
Anne Van Dyke commented, “Paris Square is, dare I say, “sexier,” than many other area age-restricted developments. Because of that we have seen more and more younger buyers coming in during this sales phase. It is clear that there is great excitement for the community in the local area and we look forward to continuing to help people find their homes at Paris Square.”
Sheryl Ritschel, Director at Coldwell Banker Realty New Homes added, “Our success at Paris Square only further underscores the critical role that effective and data-driven branding and marketing plays in the success of a real estate development. We are excited to celebrate this milestone as we grow our reputation as a trusted partner to builders, developers and Realtors across the regional single and multifamily housing community.”
Powered by the Coldwell Banker brand, Coldwell Banker Realty New Homes partners with real estate developers and Realtors through every step of the real estate marketing process to drive successful sales and leasing efforts at new residential properties. Since 1985 the Coldwell Banker Realty New Homes team has helped close over $11B in gross sales across over 20,000 homes in N.J., N.Y., Pa. and Conn.
Paris Square prices start in the mid-$400,000’s. Tours are by appointment only. For more information, visit parissquarehomes.com or call Anne Van Dyke at 201-401-1040.
LCOR, a fully integrated real estate investment, development, and management firm, today announced the topping out at The Ryland, the newly named, 267-unit, 31-story residential building located at 1 Dock Street in Philadelphia’s highly sought-after Society Hill neighborhood. The project’s construction is being led by Hunter Roberts Construction Group and is slated for final completion in Q4 of 2023.
“We are thrilled to have reached this key milestone as we move one step closer to bringing The Ryland to final completion by the end of next year,” said Peter DiLullo, Senior Vice President at LCOR. “Society Hill is neighborhood that is deeply embedded within American history and culture and we’re looking to forward to delivering an additional residential offering to the neighborhood as we continue growing our footprint with the greater Philadelphia community.”
“Hunter Roberts Construction Group is proud to be Building another successful project with LCOR and achieving this significant milestone,” said Daniel Dirscherl, Executive Vice President, Hunter Roberts Construction Group. “We look forward to being able to deliver this high-quality project on time and within budget. It has been a satisfying partnership from planning to execution.”
Upon completion, The Ryland will be comprised of 267 total residences, a mix of 44 studios, 154 one-bedroom and 44 two-bedroom apartments as well as 20 two-bedroom and 5 three-bedroom penthouse units inclusive of private outdoor deck space and condominium quality finishes. Shared resident amenity spaces to include a state-of-the-art fitness center, an outdoor pool with an accompanying roof deck and indoor rooftop lounge, multiple resident lounges throughout the building, 24/7 concierge services, a children’s playroom and on-site parking.
Located in Center City’s highly sought-after Society Hill neighborhood, The Ryland offers immediate access to the best of Historic Philadelphia inclusive of a myriad of food and beverage, shopping and art and cultural offerings. From historic landmarks such as Independence Hall and the Liberty Bell to the scenic Washington Square, the building is ideally situated in the heart of the first U.S. World Heritage City. Additionally, The Ryland benefits from its close proximity to the Market-Frankford Southeastern Pennsylvania Transportation Authority (SEPTA) line with the 2nd Street station a short walk from the property and is a short driving distance away from major area roadways and thoroughfares.
The Ryland marks LCOR’s 5th development in Pennsylvania, adding to The Birch in Conshohocken, Arlo in Malvern and 1919 Market Street and 419 Bainbridge Street in Philadelphia.
Leasing at The Ryland is projected to commence in Q3 of 2023. For more information on The Ryland, please visit Theryland.com.
Disclaimer:
